Celltrion Pharm Inc (068760)

Currency in KRW
53,100
+800(+1.53%)
Closed·
068760 Scorecard
Full Analysis
Suffers from weak gross profit margins
068760 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
52,20053,500
52 wk Range
44,50075,905
Key Statistics
Bid/Ask
53,000.00 / 53,100.00
Prev. Close
52,300
Open
52,600
Day's Range
52,200-53,500
52 wk Range
44,500-75,905
Volume
56.75K
Average Volume (3m)
119.77K
1-Year Change
-33.27%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
068760 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Celltrion Pharm Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Celltrion Pharm Inc Company Profile

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.

Employees
328

Compare 068760 to Peers and Sector

Metrics to compare
068760
Peers
Sector
Relationship
P/E Ratio
0.0x−2.1x−0.5x
PEG Ratio
0.000.030.00
Price/Book
0.0x1.1x2.6x
Price / LTM Sales
0.0x1.0x3.3x
Upside (Analyst Target)
0.0%26.0%41.6%
Fair Value Upside
Unlock9.2%5.9%Unlock

Earnings

Latest Release
May 12, 2023
EPS / Forecast
169.34 / --
Revenue / Forecast
90.01B / --
EPS Revisions
Last 90 days

068760 Income Statement

People Also Watch

176,000
068270
+2.09%
66,500
034020
+1.53%
103,200
000270
+1.38%
216,000
005380
+1.41%
106,300
042660
+2.21%

FAQ

What Stock Exchange Does Celltrion Pharm Trade On?

Celltrion Pharm is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Celltrion Pharm?

The stock symbol for Celltrion Pharm is "068760."

What Is the Celltrion Pharm Market Cap?

As of today, Celltrion Pharm market cap is 2.27T.

What Is Celltrion Pharm's Earnings Per Share (TTM)?

The Celltrion Pharm EPS (TTM) is 598.28.

From a Technical Analysis Perspective, Is 068760 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Celltrion Pharm Stock Split?

Celltrion Pharm has split 10 times.

How Many Employees Does Celltrion Pharm Have?

Celltrion Pharm has 328 employees.

What is the current trading status of Celltrion Pharm (068760)?

As of 13 Aug 2025, Celltrion Pharm (068760) is trading at a price of 53,100.00, with a previous close of 52,300.00. The stock has fluctuated within a day range of 52,200.00 to 53,500.00, while its 52-week range spans from 44,500.00 to 75,905.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.